Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAL-PDT versus cryotherapy for prevention of squamous cell carcinoma and actinic keratosis in solid organ transplant recipients
2012-004111-32Phase 3Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methyl aminolevulinate in actinic keratosis (AK), squamous cell carcinoma (SCC), sponsored by Charité – Universitätsmedizin Berlin. Started Nov 2012; status: terminated.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on 2012-004111-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004111-32.